GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » 5-Year EBITDA Growth Rate

Bangkok Genomics Innovation PCL (BKK:BKGI) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL 5-Year EBITDA Growth Rate?

Bangkok Genomics Innovation PCL's EBITDA per Share for the three months ended in Mar. 2024 was ฿0.03.

During the past 12 months, Bangkok Genomics Innovation PCL's average EBITDA Per Share Growth Rate was -47.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 32.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Bangkok Genomics Innovation PCL was 32.10% per year. The lowest was 32.10% per year. And the median was 32.10% per year.


Competitive Comparison of Bangkok Genomics Innovation PCL's 5-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bangkok Genomics Innovation PCL's 5-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's 5-Year EBITDA Growth Rate falls into.



Bangkok Genomics Innovation PCL 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Bangkok Genomics Innovation PCL  (BKK:BKGI) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Bangkok Genomics Innovation PCL 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL (BKK:BKGI) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products).

Bangkok Genomics Innovation PCL (BKK:BKGI) Headlines